National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

denileukin diftitox (DEN-ih-LOO-kin DIF-tih-tox)

 A substance used to treat cutaneous T-cell lymphoma when other treatments have not worked. It is also being studied in the treatment of chronic lymphocytic leukemia that has not responded to treatment. It belongs to the family of drugs called biological therapy agents. Also called Ontak.



Previous Definitions:dementia, Demerol, dendritic cell, dendritic cell vaccine, denial
Next Definitions:denomination, denosumab, dental implant, dentist, Denys-Drash syndrome

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov